NRIX 8-K 2026-07-09

Nurix Therapeutics, Inc. (NRIX) 8-K dated 2026-07-09 — accession 0001549595-26-000038. This URL is the filing, not the NRIX hub.

Nurix Therapeutics, Inc. (NRIX) is a biotechnology company listed on NASDAQ.

Nurix Therapeutics, Inc. filed a 8-K on 2026-07-09. Accession 0001549595-26-000038.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported NRIX revenue for 2026-05-31 was $15.3M. Net income was -$176.7M. NRIX currently screens at market cap $1.77B.

Not investment advice. The NRIX SEC hub lists recent forms. The stock page is the research view.